Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

Presentation TCT 2022

Catheter-Based Management of Infectious Endocarditis

Presenter: Abdallah El Sabbagh

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

TCT 834: The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism

Presenter: Antoon van den Enden

September 18, 2022

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

Presentation TCT 2022

Catheter-Based Thrombus Extraction Using Electro-Magnetic Fields (Magneto eTrieve™)

Presenter: Ido Weinberg

September 17, 2022

Presentation TCT 2022

A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study

Presenter: Riyaz Bashir

September 17, 2022

Presentation TCT 2022

TCT 206: Mechanical Thrombectomy Versus Catheter Directed Thrombolysis in Patients Presenting With Submassive Pulmonary Embolism: A Multi-Center Experience

Presenter: Michael Bashline

September 17, 2022

News Industry News

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 16, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Industry News

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

July 20, 2022

News Conference News SCAI 2022

Cocaine History? For Black Patients It Means Less Chance of Revascularization

L.A. McKeown

May 26, 2022

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

Presentation Fellows 2022

A cardiologist’s perspective on building a VTE program

Presenter: Sahil Parikh

May 07, 2022

Presentation Fellows 2022

The VTE landscape – where we are and where we’re going

Presenter: Shon Chakrabarti

May 07, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

Advertisement

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Catheter-Based Management of Infectious Endocarditis

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

TCT 834: The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

FLASH: More Data to Support Mechanical Thrombectomy in PE

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

Catheter-Based Thrombus Extraction Using Electro-Magnetic Fields (Magneto eTrieve™)

A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study

TCT 206: Mechanical Thrombectomy Versus Catheter Directed Thrombolysis in Patients Presenting With Submassive Pulmonary Embolism: A Multi-Center Experience

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 2022 News Roundup

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

Cocaine History? For Black Patients It Means Less Chance of Revascularization

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

A cardiologist’s perspective on building a VTE program

The VTE landscape – where we are and where we’re going

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content